Who owns Exagen Inc?
- Ticker: XGN
- CUSIP Number: 30068x103
Tip: Access positions for across all investors
Analyze quarterly positions in Exagen with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Exagen stock
Who bought or sold Exagen Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Rtw Investments | 1.5M | $6.2M | 0% | Dec 2024 |
|
| Toronto-Dominion Bank | 891k | $3.7M | 100% | Dec 2024 |
|
| Silvercrest Asset Management Group | 535k | $2.2M | -1% | Dec 2024 |
|
| Vanguard Group | 491k | $2.0M | 0% | Dec 2024 |
|
| Morgan Stanley | 484k | $2.0M | 0% | Dec 2024 |
|
| Perkins Capital Management | 424k | $1.7M | -8% | Dec 2024 |
|
| Driehaus Capital Management | 419k | $1.7M | 100% | Dec 2024 |
|
| Stonepine Capital Management | 251k | $1.0M | -53% | Dec 2024 |
|
| Kennedy Capital Management | 185k | $756k | 9% | Dec 2024 |
|
| Renaissance Technologies | 156k | $638k | -11% | Dec 2024 |
|
| Geode Capital Management | 98k | $402k | 12% | Dec 2024 |
|
| Palumbo Wealth Management | 87k | $356k | 14% | Dec 2024 |
|
| UBS Group | 64k | $263k | -18% | Dec 2024 |
|
| Nantahala Capital Management | 62k | $255k | 0% | Dec 2024 |
|
| Penbrook Managment | 45k | $183k | -29% | Dec 2024 |
|
| Daniel D. Thurber | 43k | $176k | -91% | Dec 2024 |
|
| Creative Planning | 36k | $146k | 0% | Dec 2024 |
|
| State Street Corporation | 34k | $138k | 22% | Dec 2024 |
|
| BlackRock | 33k | $137k | 0% | Dec 2024 |
|
| Dimensional Fund Advisors | 30k | $124k | 1% | Dec 2024 |
|
| Citadel Advisors | 30k | $122k | 7% | Dec 2024 |
|
| Bridgeway Capital Management | 21k | $85k | -5% | Dec 2024 |
|
| Northern Trust | 18k | $75k | 17% | Dec 2024 |
|
| Marshall Wace | 16k | $66k | 100% | Dec 2024 |
|
| Millennium Management | 16k | $65k | -30% | Dec 2024 |
|
| Prudential Financial | 15k | $60k | -33% | Dec 2024 |
|
| Virtu Financial | 11k | $46k | 100% | Dec 2024 |
|
| CI Private Wealth | 11k | $46k | 100% | Dec 2024 |
|
| Hanson McClain Advisors | 7.0k | $28k | 0% | Dec 2024 |
|
| Bank of America Corporation | 6.1k | $25k | -2% | Dec 2024 |
|
| Citigroup | 5.6k | $23k | 100% | Dec 2024 |
|
| Barclays | 5.1k | $21k | 0% | Dec 2024 |
|
| SBI Securities | 5.1k | $21k | 100% | Dec 2024 |
|
| Wells Fargo & Company | 2.4k | $9.8k | 0% | Dec 2024 |
|
| Tower Research Capital | 1.3k | $5.4k | 1% | Dec 2024 |
|
| Advisor Group Holdings | 1.0k | $3.1k | 0% | Dec 2024 |
|
| Royal Bank of Canada | 335.00 | $1.0k | 100% | Dec 2024 |
|
| Simplex Trading | 81.00 | $0 | -85% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 29.00 | $118.998600 | 100% | Dec 2024 |
|
| Jpmorgan Chase & Co | 5.00 | $21.000000 | -86% | Dec 2024 |
|
Who sold out of Exagen?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Cowen And Company | Sep 2024 | 891k | $2.8M |
| First Bank & Trust | Sep 2024 | 14k | $42k |
| Verus Capital Partners | Sep 2024 | 13k | $39k |